Moderna Inc. (NASDAQ:MRNA) on Tuesday signed a long-term strategic agreement with the Mexican government to enhance local mRNA manufacturing capabilities.

Moderna’s Strategic Agreement Boosts Mexico’s mRNA Capabilities

The agreement includes a Memorandum of Understanding that supports “Plan Mexico,” aimed at building a local mRNA ecosystem and enabling access to Moderna’s respiratory vaccine portfolio.

Moderna and the Mexican Government will also collaborate on local clinical research and development programs based on Mexico’s health priorities and work to strengthen its pandemic preparedness framework.

Additionally, the deal will facilitate technology transfer to Laboratorios Liomont for domestic production of Moderna’s COVID-19 vaccine, with a commitment to supply up to 10 million doses for the 2025-2026 vaccination campaign.

The collaboration follows recent regulatory approvals for Moderna’s COVID-19 vaccine for individuals aged six months and older, which underscores the growing demand for these vaccines in ...